Literature DB >> 15632023

Genetic difference in susceptibility to the blood-retina barrier breakdown in diabetes and oxygen-induced retinopathy.

Sarah X Zhang1, Jian-Xing Ma, Jing Sima, Ying Chen, Mark S Hu, Anna Ottlecz, George N Lambrou.   

Abstract

The breakdown of the blood-retina barrier (BRB) is a common feature of diabetic retinopathy. The purpose of the present study is to determine whether there are genetic differences in susceptibility to the breakdown of the BRB in diabetic retinopathy using two rat models. In streptozotocin (STZ)-induced diabetes, Brown Norway (BN) rats developed sustained vascular hyperpermeability in the retina during the entire experimental period (16 weeks of diabetes), while diabetic Sprague Dawley (SD) rats only showed retinal hyperpermeability from 3 to 10 days after the onset of diabetes. The strain difference in permeability was not correlated with the blood glucose levels in these two strains. In oxygen-induced retinopathy (OIR), BN rats developed retinal vascular hyperpermeability from postnatal day 12 (P12) to P22 with a peak at P16, which was 8.7-fold higher than that in the age-matched normal controls. In OIR-SD rats, however, hyperpermeability was observed from P14 to P18, with a peak only 2.2-fold higher than that in the controls. The strain difference in vascular hyperpermeability was correlated with the different overexpression of vascular endothelial growth factor (VEGF) in the retina of these two models. This finding suggests that genetic backgrounds contribute to the susceptibility to diabetic retinopathy.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15632023      PMCID: PMC1602304          DOI: 10.1016/S0002-9440(10)62255-9

Source DB:  PubMed          Journal:  Am J Pathol        ISSN: 0002-9440            Impact factor:   4.307


  54 in total

1.  Immunohistochemical localization of blood-retinal barrier breakdown in human diabetics.

Authors:  S A Vinores; C Gadegbeku; P A Campochiaro; W R Green
Journal:  Am J Pathol       Date:  1989-02       Impact factor: 4.307

2.  Permeability changes at blood-retinal barrier in diabetes and effect of aldose reductase inhibition.

Authors:  S Lightman; G Pinter; L Yuen; M Bradbury
Journal:  Am J Physiol       Date:  1990-09

Review 3.  When and how to do a grid laser for diabetic macular edema.

Authors:  F Bandello; P Lanzetta; U Menchini
Journal:  Doc Ophthalmol       Date:  1999       Impact factor: 2.379

4.  Glial reactivity, an early feature of diabetic retinopathy.

Authors:  E Rungger-Brändle; A A Dosso; P M Leuenberger
Journal:  Invest Ophthalmol Vis Sci       Date:  2000-06       Impact factor: 4.799

5.  Purification and NH2-terminal amino acid sequence of guinea pig tumor-secreted vascular permeability factor.

Authors:  D R Senger; D T Connolly; L Van de Water; J Feder; H F Dvorak
Journal:  Cancer Res       Date:  1990-03-15       Impact factor: 12.701

6.  Integrin-mediated neutrophil adhesion and retinal leukostasis in diabetes.

Authors:  F C Barouch; K Miyamoto; J R Allport; K Fujita; S E Bursell; L P Aiello; F W Luscinskas; A P Adamis
Journal:  Invest Ophthalmol Vis Sci       Date:  2000-04       Impact factor: 4.799

Review 7.  Molecular mechanisms of vascular permeability in diabetic retinopathy.

Authors:  D A Antonetti; E Lieth; A J Barber; T W Gardner
Journal:  Semin Ophthalmol       Date:  1999-12       Impact factor: 1.975

8.  Vascular permeability in experimental diabetes is associated with reduced endothelial occludin content: vascular endothelial growth factor decreases occludin in retinal endothelial cells. Penn State Retina Research Group.

Authors:  D A Antonetti; A J Barber; S Khin; E Lieth; J M Tarbell; T W Gardner
Journal:  Diabetes       Date:  1998-12       Impact factor: 9.461

9.  Sucrose permeability of the blood-retinal and blood-brain barriers. Effects of diabetes, hypertonicity, and iodate.

Authors:  S R Ennis; A L Betz
Journal:  Invest Ophthalmol Vis Sci       Date:  1986-07       Impact factor: 4.799

10.  Retinal histamine synthesis is increased in experimental diabetes.

Authors:  W J Carroll; T M Hollis; T W Gardner
Journal:  Invest Ophthalmol Vis Sci       Date:  1988-08       Impact factor: 4.799

View more
  47 in total

1.  Induction of ischemic tolerance protects the retina from diabetic retinopathy.

Authors:  Diego C Fernandez; Pablo H Sande; Mónica S Chianelli; Hernán J Aldana Marcos; Ruth E Rosenstein
Journal:  Am J Pathol       Date:  2011-05       Impact factor: 4.307

Review 2.  The mouse retina as an angiogenesis model.

Authors:  Andreas Stahl; Kip M Connor; Przemyslaw Sapieha; Jing Chen; Roberta J Dennison; Nathan M Krah; Molly R Seaward; Keirnan L Willett; Christopher M Aderman; Karen I Guerin; Jing Hua; Chatarina Löfqvist; Ann Hellström; Lois E H Smith
Journal:  Invest Ophthalmol Vis Sci       Date:  2010-06       Impact factor: 4.799

Review 3.  Genetic susceptibility to retinopathy of prematurity: the evidence from clinical and experimental animal studies.

Authors:  Gerd Holmström; Peter van Wijngaarden; Douglas J Coster; Keryn A Williams
Journal:  Br J Ophthalmol       Date:  2007-12       Impact factor: 4.638

Review 4.  Hereditary influences in oxygen-induced retinopathy in the rat.

Authors:  Peter van Wijngaarden; Helen M Brereton; Douglas J Coster; Keryn A Williams
Journal:  Doc Ophthalmol       Date:  2009-09-19       Impact factor: 2.379

5.  Nitrosative stress plays an important role in Wnt pathway activation in diabetic retinopathy.

Authors:  Qiuping Liu; Jingming Li; Rui Cheng; Ying Chen; Kyungwon Lee; Yang Hu; Jinglin Yi; Zuguo Liu; Jian-xing Ma
Journal:  Antioxid Redox Signal       Date:  2012-10-15       Impact factor: 8.401

6.  Effect of diabetes on transscleral delivery of celecoxib.

Authors:  Narayan P S Cheruvu; Aniruddha C Amrite; Uday B Kompella
Journal:  Pharm Res       Date:  2008-11-06       Impact factor: 4.200

7.  Nanoparticle-mediated expression of an angiogenic inhibitor ameliorates ischemia-induced retinal neovascularization and diabetes-induced retinal vascular leakage.

Authors:  Kyoungmin Park; Ying Chen; Yang Hu; Aaron S Mayo; Uday B Kompella; Richard Longeras; Jian-xing Ma
Journal:  Diabetes       Date:  2009-06-02       Impact factor: 9.461

8.  Inhibition of reactive oxygen species by Lovastatin downregulates vascular endothelial growth factor expression and ameliorates blood-retinal barrier breakdown in db/db mice: role of NADPH oxidase 4.

Authors:  Jingming Li; Joshua J Wang; Qiang Yu; Kai Chen; Kalyankar Mahadev; Sarah X Zhang
Journal:  Diabetes       Date:  2010-03-23       Impact factor: 9.461

9.  Inhibition of connective tissue growth factor overexpression in diabetic retinopathy by SERPINA3K via blocking the WNT/beta-catenin pathway.

Authors:  Bin Zhang; Kevin K Zhou; Jian-xing Ma
Journal:  Diabetes       Date:  2010-03-18       Impact factor: 9.461

10.  Comparison of three strains of diabetic rats with respect to the rate at which retinopathy and tactile allodynia develop.

Authors:  T S Kern; C M Miller; J Tang; Y Du; S L Ball; L Berti-Matera
Journal:  Mol Vis       Date:  2010-08-15       Impact factor: 2.367

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.